Arrowhead Pharmaceuticals (ARWR) Stock Chart & Stock Price History $19.56 +0.54 (+2.84%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Arrowhead Pharmaceuticals Stock Price Performance 5 Day Performance+3.33%1 Month Performance+0.57%3 Month Performance-7.65%6 Month Performance-30.88%Year-To-Date Performance+4.04%1 Year Performance-42.04% Receive ARWR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ARWR Stock Chart for Monday, January, 20, 2025 ARWR Chart by TradingView Arrowhead Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/20/2025$19.56$19.56$19.62$18.97927,639 shs$2.43 billion01/17/2025$19.02$19.56+2.83%$19.62$18.97927,639 shs$2.43 billion01/16/2025$18.93$19.02+0.48%$19.06$18.351.67 million shs$2.37 billion01/15/2025$18.05$18.93+4.88%$19.19$18.291.70 million shs$2.36 billion01/14/2025$18.91$18.05-4.55%$19.07$18.021.24 million shs$2.25 billion01/13/2025$18.49$18.91+2.27%$18.98$17.752.24 million shs$2.35 billion01/10/2025$19.75$18.49-6.38%$19.41$18.102.51 million shs$2.30 billion01/09/2025$19.75$19.75$20.78$19.321.72 million shs$2.46 billion01/08/2025$19.67$19.75+0.41%$20.78$19.321.72 million shs$2.46 billion01/07/2025$19.50$19.67+0.87%$20.48$19.421.20 million shs$2.45 billion Get the Latest News and Ratings for ARWR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/06/2025$19.79$19.50-1.47%$20.30$19.161.46 million shs$2.43 billion01/03/2025$19.65$19.79+0.71%$20.54$19.561.04 million shs$2.46 billion01/02/2025$18.80$19.65+4.52%$19.94$18.661.26 million shs$2.45 billion01/01/2025$18.80$18.80$19.23$18.251.23 million shs$2.34 billion12/31/2024$18.61$18.80+1.02%$19.23$18.251.23 million shs$2.34 billion12/30/2024$18.96$18.61-1.85%$19.03$18.401.13 million shs$2.32 billion12/27/2024$19.53$18.96-2.92%$20.11$18.871.35 million shs$2.36 billion12/26/2024$19.63$19.53-0.51%$19.80$19.10957,833 shs$2.43 billion12/25/2024$19.63$19.63$19.93$19.10590,049 shs$2.44 billion12/24/2024$19.75$19.63-0.61%$19.93$19.10590,049 shs$2.44 billion12/23/2024$19.45$19.75+1.54%$19.95$19.351.40 million shs$2.46 billion12/20/2024$19.50$19.45-0.26%$20.21$19.184.01 million shs$2.42 billion12/19/2024$20.36$19.50-4.22%$20.35$19.211.83 million shs$2.43 billion Related Companies Ascendis Pharma A/S Stock Price Chart Roivant Sciences Stock Price Chart Revolution Medicines Stock Price Chart Lantheus Stock Price Chart Blueprint Medicines Stock Price Chart BridgeBio Pharma Stock Price Chart Legend Biotech Stock Price Chart Elanco Animal Health Stock Price Chart Cytokinetics Stock Price Chart Nuvalent Stock Price Chart Receive ARWR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARWR) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
